| Description: |
Objectives: to evaluate the prognostic significance of early postoperative inflammatory response parameters, namely visible aqueoushumor opalescence and ciliary body thickness increase, for the effectiveness of transscleral laser cyclothermotherapy (TLCTT) in patients with primary open-angle glaucoma. Patients and methods. A retrospective analysis included 33 patients (22 men, 11 women; mean age 72.4 years) with uncontrolled primary open-angle glaucoma despite maximally tolerated hypotensive therapy. TLCTT was performed under local anesthesia with up to 16 applications delivered in the mode of 0.5 W for 20 s. Optical coherence tomography (CASIA2, Tomey, Japan) was used to assess ciliary body thickness before surgery and on postoperative day 1. Presence of aqueous humor opalescence was also recorded on day 1. Intraocular pressure (IOP) was measured by Maklakov tonometry, and topical regimen was documented preoperatively and at 1, 3, 6, and 12 months. Treatment success was defined as IOP reduction ≥ 20 % starting from 1 month.Results. Mean IOP reduction at 12 months was 8.8 ± 3.9 mmHg, corresponding to 23.8 % (p < 0.001). Treatment success was achieved in 24 patients (72.7 %). Visible aqueous humor opalescence on day 1 was observed in 24 patients (72.7 %) and correlated positively with greater IOP reduction (p = 0.008, r = 0.72). Ciliary body thickness increased significantly on day 1 postoperatively (p < 0.0001). The dynamics of thickness increase showed a strong positive correlation with IOP reduction (r = 0.86, p < 0.05). Conclusion. Early postoperative signs of intraocular inflammation and ciliary body edema can serve as reliable predictors of TLCTT effectiveness. Visible aqueous humor opalescence and increased ciliary body thickness on day 1 are associated with higher likelihood of achieving a sustained hypotensive effect within 1 month. These parameters may be recommended for early prediction of treatment outcomes in patients undergoing TLCTT for primary open-angle glaucoma. ; Цель: определить ... |
| Relation: |
https://www.ophthalmojournal.com/opht/article/view/2872/1422; Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002 Oct;120(10):1268–1279. doi:10.1001/archopht.120.10.1268.; Boland MV, Ervin AM, Friedman DS, Jampel HD, Hawkins BS, Vollenweider D, Chelladurai Y, Ward D, Suarez‑Cuervo C, Robinson KA. Comparative effectiveness of treatments for open‑angle glaucoma: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013 Feb 19;158(4):271–279. doi:10.7326/0003‑4819‑158‑4‑201302190‑00008.; Gaasterland DE, Pollack IP. Initial experience with a new method of laser transscleral cyclophotocoagulation for ciliary ablation in severe glaucoma. Trans Am Ophthalmol Soc. 1992;90:225–243; discussion 243‑246. https://pmc.ncbi.nlm.nih.gov/articles/PMC1298436/; Gelb L, Friedman DS, Quigley HA, Lyon DW, Tan J, Kim EE, Zimmerman TJ, Hahn SR. Physician beliefs and behaviors related to glaucoma treatment adherence: the Glaucoma Adherence and Persistency Study. J Glaucoma. 2008 Dec;17(8):690–698. doi:10.1097/IJG.0b013e31816b3001.; Loon SC, Jin J, Jin Goh M. The relationship between quality of life and adherence to medication in glaucoma patients in Singapore. J Glaucoma. 2015 Jun‑Jul;24(5): e36–42. doi:10.1097/IJG.0000000000000007.; Schneider KJ, Hollenhorst CN, Valicevic AN, Niziol LM, Heisler M, Musch DC, Cain SM, Newman‑Casey PA. Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Program Pilot Study on Eye Drop Instillation Technique and Self‑Efficacy. Ophthalmol Glaucoma. 2021 Jan‑Feb;4(1):42–50. doi:10.1016/j.ogla.2020.08.003.; Gaasterland DE, Pollack IP. Initial experience with a new method of laser transscleral cyclophotocoagulation for ciliary ablation in severe glaucoma. Trans Am Ophthalmol Soc. 1992;90:225–243; discussion 243–246. https://pmc.ncbi.nlm.nih.gov/articles/PMC1298436/; Iliev ME, Gerber S. Long‑term outcome of trans‑scleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol. 2007 Dec;91(12):1631–1635. doi:10.1136/bjo.2007.116533.; Seixas RCS, Russ HHA, Maestrini HA, Balbino M, Fernandes TAP, Lima NVDA, Lopes NLV, Neto TDSR. Slow coagulation versus micropulse transscleral cyclophotocoagulation for refractory childhood glaucoma. Eur J Ophthalmol. 2024 Nov;34(6):1932–1940. doi:10.1177/11206721241236920.; Ando F, Kawai T. Transscleral contact cyclophotocoagulation for refractory glaucoma: comparison of the results of pars plicata and pars plana irradiation. Lasers Light Ophthalmol. 1993;5:143.; Bloom PA, Tsai JC, Sharma K, Miller MH, Rice NS, Hitchings RA, Khaw PT. “Cyclodiode”. Trans‑scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology. 1997 Sep;104(9):1508–1519; discussion 1519–1520. doi:10.1016/s0161‑6420(97)30109‑2.; Ndulue JK, Rahmatnejad K, Sanvicente C, Wizov SS, Moster MR. Evolution of Cyclophotocoagulation. J Ophthalmic Vis Res. 2018 Jan‑Mar;13(1):55–61. doi:10.4103/jovr.jovr_190_17.; Бойко ЭВ, Куликов АН, Скворцов ВЮ. Оценка эффективности и безопасности применения диод‑лазерной транссклеральной термотерапии цилиарного тела как способа лечения рефрактерной глаукомы. Вестник офтальмологии. 2014;130(5):64–66.; Егорова ЭВ, Соколовская ТВ, Узунян ДГ, Дробница АА. Оценка результатов контактной транссклеральной диод‑лазерной циклокоагуляции с учетом изменений цилиарного тела при исследовании методом ультразвуковой биомикроскопии у больных с терминальной глаукомой. Офтальмохирургия. 2013;3:72–77.; Minhaz AT, Sevgi DD, Kwak S, Kim A, Wu H, Helms RW, Bayat M, Wilson DL, Orge FH. Deep Learning Segmentation, Visualization, and Automated 3D Assessment of Ciliary Body in 3D Ultrasound Biomicroscopy Images. Transl Vis Sci Technol. 2022 Oct 3;11(10):3. doi:10.1167/tvst.11.10.3.; https://www.ophthalmojournal.com/opht/article/view/2872 |
| Rights: |
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). ; Авторы, публикующие в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся не-эксклюзивного распространения версии работы в опубликованном здесь виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access). |